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 Abstract 
 Human 5-lipoxygenase (5-LO) can form dimers as shown 
here via native gel electrophoresis, gel fi ltration chroma-
tography and LILBID (laser induced liquid bead ion des-
orption) mass spectrometry. After glutathionylation of 
5-LO by diamide/glutathione treatment, dimeric 5-LO was 
no longer detectable and 5-LO almost exclusively exists in 
the monomeric form which showed full catalytic activity. 
Incubation of 5-LO with diamide alone led to a disulfi de-
bridged dimer and to oligomer formation which displays 
a strongly reduced catalytic activity. The bioinformatic 
analysis of the 5-LO surface for putative protein-protein 
interaction domains and molecular modeling of the dimer 
interface suggests a head to tail orientation of the dimer 
which also explains the localization of previously reported 
ATP binding sites. This interface domain was confi rmed by 
the observation that 5-LO dimer formation and inhibition 
of activity by diamide was largely prevented when four 
cysteines (C159S, C300S, C416S, C418S) in this domain 
were mutated to serines. 
 Keywords:  diamide;  5-lipoxygenase;  LILBID;  leukotrienes; 
 molecular modeling. 
 Introduction 
 5-Lipoxygenase (5-LO) is the key enzyme in the formation 
of leukotrienes (LTs) (Werz , 2002 ) which play an important 
role in infl ammatory diseases like asthma and atherosclerosis 
(Dahl é n et al., 1980 ; Funk , 2001 ). Recently, the 5-LO gene 
was identifi ed as a regulator of leukemia stem cell prolifera-
tion in BCR-ABL-induced chronic myeloid leukemia (CML) 
(Chen et al. , 2009 ). 5-LO catalyzes a two-step reaction, fi rst 
the conversion of arachidonic acid (AA) into 5(S)-hydroper-
oxy-6-trans-8,11,14-cis-eicosatetraenoic acid (5-HPETE), 
second the conversion of 5-HPETE into the allylic epoxide 
leukotriene A4 (LTA4). This unstable epoxide can be further 
metabolized to the biologically active LTB4 by LTA4 hydro-
lase or to the cysteinyl leukotriene LTC4 by LTC4 synthase 
(Shimizu et al. , 1986 ). 
 Mammalian 5-LO consists of 672 – 673 amino acids 
(Matsumoto et al. , 1988 ). The 5-LO structure published 
recently (Gilbert et al. , 2011 ) confi rms that human 5-LO con-
sists of an N-terminal regulatory C2-like domain (residues 
1 – 114) and a C-terminal catalytic domain (residues 121 – 673) 
which is mainly organized in  α -helices and contains the non-
heme iron in its catalytic center. The C2-like domain is respon-
sible for the association of 5-LO to the nuclear membrane 
(Chen and Funk , 2001 ; Kulkarni et al. , 2002 ), for diacylglyc-
eride ( H ö rnig et al., 2005 ) and calcium binding (Hammarberg 
et al. , 2000 ) and for the interaction with coactosin-like protein 
(Rakonjac et al. , 2006 ). 
 In the cell, 5-LO activity can be regulated by many 
factors. An increase in intracellular calcium leads to trans-
location of the enzyme from the cytosol to the nuclear 
membrane (Peters -Golden and Brock, 2003 ), where 5-LO 
co-localizes with 5-LO-activating protein (FLAP) and 
cytosolic phospholipase A 2 (cPLA 2 ) (Pouliot et al. , 1996 ). 
An alternative modulation of 5-LO activity is phospho-
rylation at distinct serine residues. Phosphorylations at 
Ser-271 by MAPKAP kinase 2 (Werz et al. , 2000 ) and 
at Ser-663 by ERK2 (Werz et al. , 2002 ) have a stimula-
tory effect, whereas phosphorylation at Ser-523 by protein 
kinase A (PKA) inhibits the activity (Luo et al. , 2004 ). In 
most reviews, 5-LO is mentioned as a monomeric enzyme 
(Rouzer and Samuelsson , 1985 ;  R å dmark, 2002 ), neverthe-
less, it was previously shown that 5-LO from rat basophilic 
leukemia cells (RBL-1) forms dimers in the presence of 
calcium (Parker and Aykent , 1982 ). Recently, Shang et al. 
analyzed dimerization and fl exibility of rabbit 12/15-LO 
and human 12-LO by small angle X-ray scattering (SAXS) 
(Shang et al. , 2011 ). The outcome of their study was that (i) 
r12/15-LO is mainly monomeric, but dimerizes at higher 
protein concentrations and with increasing protein fl exibil-
ity, and (ii) that human 12-LO is stable as a dimer confi rm-
ing their former studies for 12-LO (Aleem et al., 2008). 
Moreover, studies of Zhang et al. provided an additional 
hint for a 5-LO dimer (Zhang et al. , 2000 ). They performed 
affi nity and photoaffi nity labeling experiments with 5 ′ - p -
fl uorosulphonylbenzoyladenosine (FSBA) and 2-azido-
ATP and identifi ed the amino acids 73 – 83 and 193 – 209 as 
ATP-binding sites within the enzyme. The stoichiometry 
suggested an equimolar ratio of ATP and 5-LO. This led us 
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to the assumption that both peptides must be nearby in the 
tertiary structure forming one ATP binding site. Regarding 
the crystal structure of Stable-5LOX, this could be only 
true if 5-LO forms dimers/multimers, as one postulated 
ATP binding site is located in the C2-like domain, the other 
in the catalytic domain. 
 Herein, we describe the fi rst time that human recombinant 
5-LO and 5-LO purifi ed from PMNL forms dimers. 
 Results 
 Analysis of 5-LO dimer formation by native gel 
electrophoresis, gel fi ltration and LILBID-MS 
 In order to examine the oligomeric state of 5-LO we fi rst 
performed native gel electrophoresis. Both, recombinant 
5-LO that was expressed in  Escherichia coli as well as 5-LO 
from PMNL were purifi ed via ATP-agarose and applied to a 
native Tris-HCl PAGE. The resulting gel was analyzed via 
Coomassie staining and Western blot. Two major 5-LO bands 
were identifi ed which suggested that 5-LO may form dimers 
(Figure  1 A). 
 In order to confi rm dimerization of 5-LO, LILBID-MS 
and gel fi ltration chromatography was applied. The resulting 
LILBID spectra of 5-LO WT showed monomeric as well as 
dimeric and even a little trimeric enzyme (Figure  1 B). 
 For gel fi ltration, PB/EDTA with addition of 0.15  m up to 
1  m NaCl was used. We observed an elution profi le consisting 
of one large peak at an apparent MW of 30 kDa and some 
smaller peaks which eluted earlier (Figure  1 B). The late elu-
tion of the 5-LO peak at an apparent MW of 30 kDa is prob-
ably due to unspecifi c interaction with the column material. 
Repetition of the experiment in PBS/EDTA with addition of 
0.5 % T20 to reduce this interaction led to the expected MW 
of 75 kDa for the main peak (Figure  2 A) and to a smaller 
peak at an apparent MW of about 160 kDa. SDS-PAGE and 
Western blot analysis confi rmed that both peaks consist of 
5-LO (Figure  2 E). Addition of ATP (1 m m ) or calcium (1 m m ) 
to the sample buffer and the mobile phase did not change the 
5-LO elution profi le (data not shown). 
 In LILBID-MS and in gel fi ltration, the presence of T20 
micelles led to a strong increase in 5-LO dimers indicating that 
the interaction of 5-LO with micelles induces its dimerization 
(compare Figures  1 B,  2 A and  3 ). 
 Modifi cation of 5-LO by GSH and diamide 
 Since 5-LO contains 10 cysteines on the protein surface we 
wanted to investigate the effect of glutathionylation of the 
cysteines and the associated changes in 5-LO surface prop-
erties on 5-LO dimerization (Figure  4 A). Glutathionylation 
of 5-LO was performed by addition of GSH and diamide as 
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 Figure 1  Analysis of 5-LO WT w/o T20. 
 (A) Native gel electrophoresis of recombinant 5-LO WT and 5-LO from PMNL. 5-LO was detected with anti-5-LO antibody after blotting 
to a nitrocellulose membrane or with Coomassie blue staining. (B) LILBID spectra of 6.4  µ m 5-LO in 100 m m NH 4 HCO 3 and gel fi ltration 
chromatogram of 2 mg 5-LO in PB/EDTA + 0.5  m NaCl. 
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 Figure 2  LILBID spectra and gel fi ltration chromatograms of 5-LO WT in the presence of T20. 
 Arrows are marking the elution volumes of the reference proteins conalbumin (75 kDa) and aldolase (158 kDa). LILBID spectra of (A) 6.4  µ m 
5-LO in 100 m m NH 4 HCO 3 + 0.1 % T20 and gel fi ltration of 2 mg 5-LO in PBS/EDTA + 0.5 % T20, (B) 6.4  µ m 5-LO incubated with 25 m m GSH 
and 2.78 m m diamide for 30 min at 37 ° C in PBS/EDTA + 0.1 % T20 followed by buffer exchange to 100 m m NH 4 HCO 3 + 0.1 % T20, (C) 6.4  µ m 
5-LO incubated with 2.78 m m diamide for 10 min at 37 ° C in PBS/EDTA, afterwards the buffer was exchanged to 100 m m NH 4 HCO 3 + 0.1 % 
T20. The right panels shows the corresponding gel fi ltrations (mobile phase PBS/EDTA + 0.5 % T20) of 2 mg 5-LO incubated under the respec-
tive conditions of the LILBID analysis. (D) LILBID spectrum of 6.4  µ m 5-LO that was preincubated with 2.78 m m diamide for 10 min at 37 ° C 
in PBS/EDTA followed by buffer exchange to 100 m m NH 4 HCO 3 . (E) SDS-PAGE analysis with Coomassie blue staining of gel fi ltration frac-
tions of the 5-LO monomer (79 ml) and dimer (70 ml) peak from panel A. 
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oxidizing agent (Kosower and Kosower , 1995 ). To investi-
gate the infl uence of a glutathione modifi cation on the oligo-
meric state of the enzyme, 5-LO was incubated with GSH (10 
m m ) plus diamide (1 m m ) for 30 min at 37 ° C or diamide alone 
(1 m m ) for 10 min at 37 ° C. 
 Treatment of 5-LO with GSH and diamide led to the almost 
exclusive formation of monomers in LILBID-MS and on gel 
fi ltration in the presence of T20 (Figure  2 B). LILBID mea-
surements were performed in the presence of T20 (Figure 
 2 A – C), no T20 was added in Figure  2 D. 
 Obviously, treatment of 5-LO with GSH and diamide pre-
vents dimerization. To demonstrate glutathionylation of 5-LO 
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 Figure 3  Oligomer distribution of 5-LO WT under different condi-
tions in LILBID-MS analysis. Distribution is shown as percentage of 
overall signal + SEM (n = 3). 
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 Figure 4  Protein-protein docking of 5-LO and cysteine residues in the putative dimer-interface and on the surface. 
 (A) Structure of human 5-LO with the surface exposed cysteines (yellow spheres). C598 is partially buried. (B) The most reasonable docking 
solution, exhibiting a head-to-tail orientation, in cartoon representation with semi-transparent surface. Highlighted are the two proposed ATP 
binding sites in red, together with the cysteines (yellow spheres) in the predicted dimer interaction interface. The cysteines in the red square 
(C159, C416, C418) might be suffi ciently close to allow for disulfi de bond formation. 
under these conditions, the enzyme was incubated with ( 35 S)-
GSH in the presence of diamide. After separation by SDS-
PAGE, glutathionylation was detected with a phosphorimager. 
Maximal glutathionylation of 5-LO was achieved when GSH 
was combined with diamide and H 2 O 2 as oxidant to quench the 
DTT contained in the ( 35 S)-GSH solution whereas addition of 
GSH and diamide still leads to lower, but detectable glutathio-
nylation (Figure  5 , lanes 3 and 4). To quantify the glutathio-
nylation of 5-LO, free cysteine residues were quantifi ed using 
Ellman ’ s reagent and HPLC analysis (Chen et al. , 2008 ). We 
found that treatment of 5-LO with GSH (10 m m ) and diamide 
(1 m m ) leads to a reduction in the number of free cysteine resi-
dues from 10 in the unmodifi ed 5-LO to nine indicating that 
one cysteine residue becomes glutathionylated. 
 Interestingly, treatment of 5-LO with diamide alone for 10 
min at 37 ° C (Figure  2 C) completely prevented monomer for-
mation on gel fi ltration and led to a peak that corresponded to 
dimers. Elongation of the incubation time led to the forma-
tion of even higher molecular complexes. The formation of 
disulfi de bonded 5-LO dimers and oligomers as consequence 
of the incubation with diamide can be seen in the LILBID 
spectra both in the presence or absence of T20 (Figure  2 C 
and D). Thus, oxidation of the enzyme and formation of inter-
molecular disulfi de bridges by diamide induced a shift of the 
size distribution to higher masses concomitant with a deple-
tion of the monomer. For summary of oligomer distribution in 
LILBID-MS of 5-LO WT see Figure  3 . 
 Analysis of dimer formation in PMNL S100 
by gel fi ltration 
 PMNL S100 was analyzed by gel fi ltration in PBS/EDTA. 
5-LO activity as well as 5-LO protein (by Western blot) was 
found in a broad range of fractions from about 60 to 90 ml 
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with the main activity eluting at 75 ml (Figure  6 ). Since the 
gel fi ltration was performed without T20 in the elution buffer, 
it can be assumed that there is a shift to a smaller MW due 
to interaction with the column material, comparable to the 
recombinant 5-LO in the same buffer (dotted line). Despite 
this, 5-LO activity was also found in fractions that elute at an 
apparent MW of the dimer indicating that at least a part of the 
5-LO could exist as dimer in PMNL. 
 Molecular modeling and docking of 5-LO 
 To establish a model of a 5-LO dimer, we used the crystal struc-
ture of engineered human 5-LO {Protein Data Bank [PDB, 
http://pdb.org, (Berman et al. , 2000 )], ID: 3o8y (Gilbert et al. , 
2011 )}. Gilbert et al. mutated or deleted several amino acids 
to obtain the so-called  ‘ Stable-5LOX ’ (Gilbert et al. , 2011 ) 
thereby enabling crystallization and structure determination. 
To restore the WT enzyme, we performed  in silico mutagenesis 
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 Figure 6  Gel fi ltration analysis of recombinant 5-LO and PMNL 
S100. 
 Gel fi ltration chromatography of 2 mg purifi ed 5-LO (dotted line) 
and of PMNL S100 (continuous line) from 2 × 10 9 cells using PBS/
EDTA as mobile phase. 5-LO in the PMNL S100 was recorded by 
determination of 5-LO activity in the fractions and detection of 5-LO 
by Western blot analysis with 5-LO antibody (marked with arrow; 
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 Figure 5  SDS-PAGE analysis of ( 35 S)-GSH incorporation into 
5-LO. 
 Purifi ed 5-LO WT was incubated with ( 35 S)-GSH and then sub-
jected to SDS-PAGE analysis. GSH incorporation was detected by 
a Phosphorimager. Lane 1, 5-LO treated with 0.87 m m diamide, 2.5 
 µ Ci ( 35 S)-GSH; lane 2, 0.87 m m diamide, 0.87 m m H 2 O 2 , 2.5  µ Ci 
( 35 S)-GSH; lane 3, 3.48 m m diamide, 2.5  µ Ci ( 35 S)-GSH; lane 4, 3.48 
m m diamide, 0.87 m m H 2 O 2 , 2.5  µ Ci ( 35 S)-GSH; lane 5, 0.87 m m 
diamide; in all lanes: 8.7 m m GSH, 17.4  µ l 5-LO. 
and constructed the completed structure of 5-LO WT. For this 
structure, we predicted potential dimerization sites using four 
independent software tools. All proposed interfaces (Figure  7 ) 
have one side of 5-LO in common, which is fl anked by the two 
putative ATP binding sites K73-K83 and F193-K209 (Figure 
 7 A). The predicted interaction site was then used to evaluate 
the proposed complex conformations by protein-protein dock-
ing performed with the protein docking and clustering tech-
nique ClusPro. ClusPro was the best performing server in the 
last round of CAPRI (Critical Assessment of PRediction of 
Interactions), a community wide experiment on the compara-
tive evaluation of protein-protein docking for structure pre-
diction ( http://www.ebi.ac.uk/msd-srv/capri/ ) (Janin , 2005 ). 
Suggested docked conformations were fi ltered so that only 
those complexes were retained whose dimerization site was in 
agreement with the predicted interface region. Assuming that 
both proposed ATP binding regions form a coherent ATP bind-
ing site, which is possible in a putative 5-LO dimer/multimer, 
we considered only those complexes fulfi lling these criteria. 
Among these complexes, we selected the number one ranked 
docking solution as fi nal model (Figure  4 B). It exhibits coher-
ent ATP binding sites, matches the predicted interface regions, 
and represents the biggest cluster of docking solutions; there-
fore it was ranked highest by the clustering algorithm. This 
fi nal model constitutes the 5-LO subunits in a head-to-tail ori-
entation, where the C2-like domain of one subunit interacts 
with the catalytic domain of the other. We found four cysteines 
in the putative interface three of which (C159, C416, C418) 
might be suffi ciently close to allow for intermolecular dis-
ulfi de bond formation (Figure  4 B), which might explain the 
observed diamide-induced dimerization. 
 The reactivity of protein thiols depends on the pK 
a
 value and 
the accessibility of the thiol, both of which can vary widely. 
Although protein thiols typically have pK 
a
 values of 8.5–9, 
these can largely vary depending on the local environment of 
the cysteine residue (Gilbert , 1984 ; Simplicio et al. , 1998 ). 
Therefore, we calculated the pK 
a
 values for the cysteines of 
5-LO using the PROPKA program (Li et al. , 2005 ; Bas et al. , 
2008 ). All of the predicted interface cysteines have calculated 
pK 
a
 values of around 9 in the protein environment (C159: 8.5; 
C300: 9; C416: 8.5; C418: 9; C598: 9.3) which is in agreement 
with possible glutathionylation/disulfi de-bond formation. 
 Evaluation of the predicted dimer interface 
 We compared the predicted 5-LO interface with interfaces 
of 534 non-homologous homodimers. Therefore we used the 
PROTORP server (Reynolds et al. , 2009 ), which analyzes 
protein-protein complex formation by calculating a series of 
physical and chemical parameters of the protein interaction 
sites that contribute to the binding free energy of the associa-
tion. These parameters include size and shape, intermolecular 
bonding, residue and atom composition, as well as secondary 
structure contributions. The protein association parameters 
for our dimer model were calculated and compared to those 
observed in known homodimers (Figure  8 A; for abbrevia-
tions see supplementary Table  S1 ). For 24 out of the 26 com-
puted parameters the values for the predicted 5-LO dimer are 
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within the mean ± SD of the known complexes. Deviations 
from a  ‘ typical ’ homodimer were detected for the total num-
ber of surface residues (858.0 instead of 380.5 ± 202.6) and the 
expected percentage of β-sheets in the interface (20.2 ± 19.4) 
as no β-sheets are predicted for 5-LO. 
 Mutation of four cysteines prevents diamide-induced 
5-LO dimerization 
 5-LO contains 13 cysteines and according to the restored 
5-LO WT 10 of the cysteines are located on the protein sur-
face. Four of these cysteines are located close to each 
other at a putative reactive site, which could be impor-
tant for the dimer formation in a head-to-tail conformation 
(cf. Figure  4 ). In order to test the hypothesis that this interface is 
involved in 5-LO dimer formation and that these four cysteines 
are involved in diamide-induced 5-LO dimerization by forma-
tion of intermolecular disulfi de bridges, we designed a 4C mutant 
in which four cysteines (C159S, C300S, C416S, C418S) were 
replaced with serines. The resulting gel fi ltration chromatogram 
of the 4C mutant in presence of T20 and after preincubation 
with GSH and diamide was similar to the chromatogram of the 
unmodifi ed and modifi ed WT (Figures  2 A, B,  and 9 A, B). When 
the 4C mutant was treated with diamide only, the majority of 
the 4C 5-LO still eluted as monomer and only a minor fraction 
eluted as dimer (Figure  9 C) whereas no monomer was detect-
able with the WT 5-LO under these conditions (Figure  2 C). 
Formation of covalent dimers by diamide was analyzed with 
SDS-PAGE without addition of  β -mercaptoethanol and detected 
by Coomassie staining. As shown in Figure  10 , diamide-treated 
WT 5-LO gives a main band at an apparent molecular weight 
of about 150 kDa, whereas the main band of the 4C mutant 
was detected at 75 kDa. After boiling of the protein samples 
with  β -mercaptoethanol, only one band was detectable with 
SDS-PAGE at 75 kDa with WT 5-LO as well as with the 4C 
mutant indicating that the dimers a linked via disulfi de bridges. 
Similarly, in PMNL only 5-LO monomers were observed when 
5-LO was analyzed under denaturing conditions both in the 
presence and absence or presence of  β -mercaptoethanol (Figure 
 10 ) indicating that the 5-LO dimers observed under non-dena-
turing conditions (Figure  1 A) are not covalently linked. 
 In LILBID-MS, the 4C mutant existed almost exclusively 
as monomer, even in presence of T20 or diamide suggesting 
that the four cysteines exchanged to serines in the 4C mutant 
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are mainly responsible for diamide-induced dimerization of 
the 5-LO WT enzyme (Figure  9 ). 
 Functional studies on 5-LO WT and 4C mutant 
 5-LO WT and the 4C mutant show similar catalytic activi-
ties indicating that the mutations do not signifi cantly alter the 
5-LO structure (Table  1 ). When 5-LO was incubated in the 
presence of T20, the specifi c activity was reduced from 534 to 
86 ng/ µ g protein (Table 1) so that it retained only about 15 % 
of its normal activity and activity loss increased with time 
leading to almost no detectable products when 5-LO was kept 
in a T20 containing buffer overnight before the activity was 
determined. This activity loss explains the low specifi c activ-
ity of the enzyme after gel fi ltration overnight in the pres-
ence of T20 (about 4 ng 5-LO products per  µ g protein). When 
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freshly purifi ed 5-LO was treated with diamide for 10 min, 
5-LO activity was reduced from 534 to 23 ng/ µ g protein which 
corresponds to about 4 % of the activity of the control (Table 
1). In contrast, diamide did not inhibit the 4C mutant which 
is of interest since the reagent also failed to induce dimeriza-
tion of the 4C mutant (Figure  9 ). Also, the inhibitory effect 
of T20 was less pronounced with the 4C mutant. Combined 
GSH and diamide treatment led to similar activities as in the 
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 Figure 9  LILBID spectra and gel fi ltration chromatograms of 4C mutant. 
 Arrows are marking the elution volumes of the reference proteins conalbumin (75 kDa) and aldolase (158 kDa). LILBID spectra of (A) 6 
 µ m 4C in 100 m m NH 4 HCO 3 + 0.1 % T20, (B) 6  µ m 4C mutant incubated with 25 m m GSH and 2.78 m m diamide for 30 min at 37 ° C in PBS/
EDTA + 0.1 % T20, afterwards the buffer was exchanged to 100 m m NH 4 HCO 3 + 0.1 % T20, (C) 6  µ m 4C mutant incubated with 2.78 m m diamide 
for 10 min at 37 ° C in PBS/EDTA, afterwards the buffer was exchanged to 100 m m NH 4 HCO 3 + 0.1 % T20 and (D) 6  µ m 4C mutant in 100 m m 
NH 4 HCO 3 . The right panels show the gel fi ltration analysis (mobile phase PBS/EDTA + 0.5 % T20) of 2 mg 4C mutant after incubation under 
the same conditions as for LILBID analysis. 
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 Figure 10  SDS-PAGE analysis of WT 5-LO, 4C mutant and PMNL 
S100. 
 Coomassie staining with or without BME of either (1) WT 5-LO or 
(2) 4C mutant treated with 1 m m diamide and (3) WB of PMNL S100 
with or without BME. 
 Table 1  Enzyme activity of 5-LO WT and the 4C mutant. 
WT 5-LO
(ng products/ µ g protein)
4C 5-LO
(ng products/ µ g protein)
w/o 534 ± 7 436 ± 11
GSH/diamide 557 ± 5 442 ± 8
Diamide 23 ± 1 486 ± 19
T20 86 ± 3 299 ± 19
T20/GSH/
Diamide
72 ± 4 258 ± 3
T20/diamide 9 ± 2 299 ± 5
 Purifi ed protein was either used without or with preincubation with 
10 m m GSH and 1 m m diamide for 30 min at 37 ° C or with 1 m m 
diamide for 10 min at 37 ° C. Activity assays were performed in PBS/
EDTA with 2 m m Ca 2 +  , 1 m m ATP and 20  µ m AA with or without 
0.5 % T20. Enzyme activity is given as ng products per  µ g protein  ± 
SEM (n = 3). 
untreated control in the WT enzyme as well as the 4C mutant, 
suggesting that glutathionylation does not signifi cantly affect 
5-LO activity (Table 1). 
 Discussion 
 In this work we investigated the dimerization of human 
5-LO. The protein plays a key role in leukotriene formation in 
infl ammation and host defense reactions (Samuelsson , 1983 ). 
Although it was never studied in detail, 5-LO is generally 
considered to be a monomeric enzyme. It catalyzes two dif-
ferent reaction steps, consisting of an initial oxygenation step 
at C5 of arachidonic acid, followed by dehydration and for-
mation of leukotriene A 4 . This led us to speculate that 5-LO 
could form a dimeric complex, where one monomer of the 
homodimer catalyzes the generation of 5-HPETE which is 
then transferred to the other monomer for the formation of 
LTA 4 . Alternatively, for COX which catalyzes the initial steps 
in prostaglandin biosynthesis by the oxygenation of arachi-
donic acid, Yuan et al.  (2009) showed that COX forms dimers, 
where one substrate molecule binds with high affi nity to one 
COX site and facilitates the oxygenation of arachidonic acid 
by the other catalytic partner (Yuan et al. , 2009 ). According to 
these data we assumed that one monomer of the 5-LO could 
be the catalytically active partner whereas the other monomer 
has a regulatory function, e.g., via its pseudoperoxidase activ-
ity (Riendeau et al. , 1991 ). 
 By gel fi ltration, native PAGE and LILBID-MS analy-
sis, we found that 5-LO can form dimers and that dimer 
formation is enhanced in the presence of T20 micelles. 
Rechromatography of the monomeric peak leads again to 
the typical monomer/dimer pattern indicating that there is 
a dynamic balance between monomers and homodimers 
(data not shown). Neither calcium nor ATP enhanced 5-LO 
dimerization. 5-LO dimers were reported for rat 5-LO in the 
presence of calcium, and 5-LO activity was attributed to the 
dimeric form (Parker and Aykent , 1982 ). With the human 
enzyme, we cannot confi rm this observation. In accordance 
with Hammarberg et al. (Hammarberg and R å dmark, 1999 ) 
we found no evidence that Ca 2 +  promotes 5-LO dimer for-
mation. This is supported by our diamide experiments. 
Treatment of 5-LO with GSH/diamide leads to glutathiony-
lation of 5-LO which alters the surface properties of 5-LO 
and prevents dimer formation as shown with LILBID-MS 
and gel fi ltration. However these  ‘ forced ’ 5-LO monomers 
displayed similar catalytic activity as the untreated enzyme 
suggesting that monomers seem to have similar catalytic 
properties as the untreated enzyme consisting of monomers 
and dimers (Table 1). 
 Though, different reaction kinetics for both quaternary 
structures are conceivable, similarly to what was already 
discussed for 12-LO (Aleem et al. , 2008 ) and 15-LO2 
(Wecksler et al. , 2009 ). An impact of dimerization on the 
reaction kinetics is presumable due to the observation that 
the predicted dimer interface is located at the proposed sub-
strate and oxygen entry site of LOs (Ivanov et al. , 2010 ). 
Although an entry channel to the active site is not directly 
present in the crystal structure of 5-LO, substrate entry to 
the catalytic site is expected via conformational changes by 
amino acids of the so called  ‘ FY-cork ’ in this region that 
closes the active site (Gilbert et al. , 2011 ). However, due 
to the dynamics of the monomer/dimer equilibrium and the 
very low enzymatic activity of the covalently linked dim-
ers generated by diamide treatment, kinetic experiments on 
monomers or dimers are diffi cult to perform. At present, we 
cannot rule out that dimerization leads to a shift in the 5-LO 
product pattern. 
 Addition of diamide to 5-LO (without GSH) yielded 
mainly dimers and to a low extent even trimers or tetramers 
depending on the incubation time as shown by gel fi ltration 
and LILBID-MS. These 5-LO dimers were also detected by 
SDS-PAGE (in the absence of  β -mercaptoethanol) whereas 
the SDS-PAGE bands corresponded to the 5-LO monomer 
when  β -mercaptoethanol was added indicating that diamide 
induces 5-LO dimers in which both proteins are linked by 
intermolecular disulfi de bridges. Interestingly, the covalently 
linked 5-LO dimers displayed a rather low catalytic activity. 
This could be explained by intermolecular disulfi de bonds that 
are formed between both monomers and thus according to our 
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model block the entrance to the catalytic center or avoid a 
conformational change that is necessary for catalytic activity. 
 For establishing a model of the 5-LO/5-LO interaction, 
we used the just-deposited crystal structure of human 5-LO 
[PDB ID: 3o8y (Gilbert et al. , 2011 )] and restored the WT 
enzyme ( in silico mutation and insertions of the modifi ed 
amino acids). 3o8y shows a crystallographic dimer, which 
is not a thermodynamically stable complex (Shang et al. , 
2011 ). Therefore, this assembly might solely rise from 
crystal-packing. Again, (i) 3o8y was engineered which 
might affect its oligomeric state and (ii) since our observa-
tions suggest a monomer-dimer equilibrium the conforma-
tion of the weak dimer might not be captured in the crystal 
structure where the crystallization conditions can lead to 
numerous non-physiological associations (Dafforn , 2007 ). 
By using computational prediction algorithms for protein-
protein interaction sites, we established a model for a 5-LO 
dimer (Figure  4 B). Protein-protein interfaces are evolution-
arily more conserved than the rest of the protein surface, 
which has recently been verifi ed using a large protein struc-
tural dataset (Choi et al. , 2009 ). This might also be true 
for weak dimers that are in equilibrium with the monomer 
in solution (Dey et al. , 2010 ). Thus, we analyzed the con-
servation of the predicted dimer interface of human 5-LO 
(Figure  8 B). The results suggest that the predicted interface 
is, apart from the C2-like domain region and in contrast to 
the rest of the surface, conserved between rat and human 
5-LO. Predicted interface parameters support the feasibility 
of the 5-LO dimer. In our model, four cysteines are located 
in the interface domain, three of which (C159, C416, C418) 
are in close spatial proximity suggesting disulfi de bridge 
formation upon diamide treatment. In order to verify our 
dimer model, we mutated all four cysteine residues and 
found that mutation of these cysteines largely prevent 
diamide-induced dimer and oligomer-formation. This is in 
line with the observation that diamide treatment of the 4C 
mutant does not inhibit its catalytic activity whereas the 
WT-enzyme is strongly inhibited. Furthermore, since we 
have demonstrated that the 4C mutant exists mostly as a 
monomer in the presence of GSH and diamide, one could 
speculate that GSH binds to C598, which is located in the 
suggested dimer interface (cf. Figure  4 ), thereby prevent-
ing dimerization of 5-LO. Another argument supporting our 
dimer model and the head-to-tail orientation of the dimer 
is the location of the ATP binding site, where two other-
wise distant tryptophans, which were previously labeled by 
azido-ATP (Zhang et al. , 2000 ), are in close proximity to 
each other (Figure  4 B). Such a model, where two ATP mol-
ecules are bound by the dimer, is in agreement with the pre-
viously reported equimolar ratio of 5-LO and ATP (Zhang 
et al. , 2000 ). Although the experimental results correlate 
well with the proposed dimer model, we are fully aware 
that molecular modelling is prone to errors. Nevertheless, 
as this is the fi rst suggested model of the putative dimer of 
5-lipoxygenase, we hope that it will serve as a valid work-
ing tool for generating hypotheses. The herein described 
5-LO dimerization interface opens up novel opportunities 
for the design of inhibitors. The feasibility of this approach, 
designing protein-protein interaction inhibitors, has been 
demonstrated recently (for review see Gonz á lez-Ruiz and 
Gohlke, 2006 ; Grosdidier et al. , 2009 ). Up to now, there 
are three main types of direct 5-LO inhibitors known: iron 
ligand type, redox type, and non-redox type inhibitors. 
(Ford-Hutchinson et al., 1994). Due to several short com-
ings, only one 5-LO inhibitor could reach the market to date, 
the iron ligand type inhibitor zileuton (Carter et al. , 1991 ). 
The interference with 5-LO function via modulation of the 
protein-protein complex might open up a novel approach 
to identify small molecule inhibitors to interfere with 
LT-mediated diseases. It should also be mentioned that the 
proposed model represents a dimeric complex only and that 
higher oligomers might exhibit different conformations. 
 Interestingly, our LILBID-MS-data suggest that T20 
micelles promote 5-LO dimerization (Figure  3 ). Assuming 
that T20 micelles mimic cell membranes and thus provide 
a lipophilic surface for 5-LO to interact with, it is possi-
ble that in stimulated intact cells, interaction of 5-LO with 
the membrane after translocation from the cytosol induces 
dimerization. Arachidonic acid, either supplied exogenously 
or released by cPLA 2 has been shown to induce 5-LO 
translocation which could be blocked by a FLAP inhibi-
tor (Flamand et al. , 2006 ). 5-LO dimerization after 5-LO 
translocation and interaction with FLAP is supported by a 
previous observation where an 186 kDa 5-LO containing 
complex was found in cross-linking experiments in Sf9 
cells when FLAP was coexpressed but not in the absence 
of FLAP (Plante et al. , 2006 ). Since FLAP is a membrane-
bound protein which is required for AA transfer after 5-LO 
translocation to the nuclear membrane following cell stimu-
lation it might be possible that interaction of 5-LO with the 
membrane and FLAP triggers dimerization and leukotriene 
formation. 
 An interesting phenomenon is the increased dimerization 
of the WT enzyme by T20 as shown by LILBID analysis 
(Figure  2 A) which is accompanied with a 85 % decrease in 
5-LO activity whereas the 4C mutant is only inhibited by 30 % 
and does not show dimerization after short-term exposure to 
T20 in LILBID analysis (Figure  9 D). This might give a hint 
that 5-LO dimers show reduced catalytic activity but it might 
on the other hand simply be due to the fact that the 4C mutant 
is more resistant to detergent treatment. 
 From our data it is clear that the 5-LO monomer shows 
full catalytic activity. Furthermore, our data show for the fi rst 
time that leukotriene biosynthesis obviously does not require 
5-LO dimerization. However, our study gives only limited 
hints on the catalytic activity of the dimer. The low enzyme 
activity observed after diamide-induced dimerization and in 
the presence of T20 micelles could be related to the covalent 
linkage of the dimers and to detergent effects, respectively. 
The fact that T20 also inhibits enzyme activity of the mono-
meric GSH/diamide-treated 5-LO suggests that the inhibition 
of 5-LO activity is not related to dimerization. In the native 
enzyme, it is impossible to selectively detect the activity of 
the dimer as gel fi ltration experiments with rechromato graphy 
of the monomeric peak led to the usual monomer/dimer dis-
tribution again. 
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 Taken together, we could show that 5-LO can form dimers 
and that there is a dynamic equilibrium between the mono-
meric and dimeric form. Treatment of 5-LO with GSH and 
diamide prevents dimerization whereas addition of diamide 
alone leads to disulfi de-linked 5-LO dimers and oligomers. 
The 5-LO monomer displayed similar catalytic properties as 
the native enzyme suggesting that dimerization is not required 
for leukotriene biosynthesis. 
 However, due to the nuclear localization of 5-LO and its 
association with euchromatin or to its interaction with dicer, 
other biological roles were proposed for 5-LO apart from 
leukotriene biosynthesis, such as regulation of gene expres-
sion or miRNA processing, respectively (Woods et al. , 1995 ; 
Dincbas -Renqvist et al., 2009 ). Thus, dimerization could be 
of relevance for the proposed alternative 5-LO functions. In 
our gel fi ltration experiments with PMNL supernatants, 5-LO 
eluted in fractions corresponding to the monomer but the 
enzyme was also detected in fractions corresponding to the 
dimer and to higher molecular weights. Furthermore, purifi ed 
5-LO from PMNL also formed dimers. A possible explana-
tion could be that a part of the 5-LO exists as dimer and/or in 
a complex with other soluble proteins. It is known that 5-LO 
in B-lymphocytes can be activated by treatment with diamide 
(Jakobsson et al. , 1992 ). Thus, it is reasonable to assume that 
in the presence of high intracellular GSH levels, diamide leads 
to the glutathionylation of 5-LO. This could, for example, pre-
vent the interaction of 5-LO with an endogenous inhibitor. 
 Materials and methods 
 Site-directed mutagenesis 
 Selected cysteine codons were mutated by using the QuikChange kit 
from Stratagene according to manufacturer ’ s protocol (for primer se-
quence see Table  2 ). Mutations were confi rmed with the ABI PRISM 
dye terminator cycle-sequencing ready-reaction kit (PerkinElmer, 
Waltham, MA, USA), followed by analysis on a PRISM 377 se-
quencer (Applied Biosystems, Carlsbad, CA, USA). 
 Expression and purifi cation of mutated and WT 5-LO 
 Recombinant 5-LO was expressed in  E.coli BL21 (DE3) cells. 
The cells were transformed with pT3-5LO (kindly provided by 
Olof Rådmark), and preparation of the enzyme was performed 
as described previously (Fischer et al. , 2003 ). Further purifi ca-
tion was performed by anion exchange column chromatography 
as described previously (Brungs et al. , 1995 ). In brief, the ATP-
eluate (10 ml) was loaded on a ResourceQ 6 ml column (GE 
Healthcare, Uppsala, Sweden). Buffer A was phosphate-buffer 
0.05 m m , pH 7.4 containing 1 m m EDTA, buffer B was buffer A plus 
0.5  m NaCl. The elution of the 5-LO was performed in a gradient from 
0 % to 100 % buffer B and the enzyme eluted at about 40 % buffer B. 
Either the partially purifi ed 5-LO obtained after ATP-agarose ( ∼ 90 % 
purity) or purifi ed 5-LO ( ∼ 98 % purity) was used for the experiments. 
 Isolation of PMNL from leukocyte concentrates 
 Blood bags were combined and diluted 1:1 (v:v) with PBS pH 7.4. To 
each 40 ml of diluted concentrates, 10 ml of dextrane-PBS solution 
(100 g/l) were added, mixed and sedimented for 30 min. Each 10 ml 
Nycoprep medium were overlaid with 40 ml of the supernatants and 
centrifuged at 800  g for 10 min at room temperature without deceler-
ation. The supernatant was discarded and the pellet was resuspended 
in 50 ml ice-cold PBS pH 7.4. After re-centrifugation at 300  g for 
10 min at room temperature with deceleration, the supernatant was 
discarded and the pellets were resuspended in 10 ml ice-cold water 
for lysis of erythrocytes. After 45 s, lysis was stopped by adding 
40 ml PBS pH 7.4 at room temperature. The cells were centrifuged 
at 200  g for 10 min, washed with PBS pH 7.4 and lysed again. After 
re-centrifugation at 200  g for 10 min at room temperature, the pellet 
was resuspended in glucose/PBS medium (1 mg/ml). 
 Sample preparation and gel fi ltration 
of recombinant 5-LO 
 Modifi ed 5-LO was obtained by incubating 2 mg of 5-LO with GSH 
(10 m m ), GSSG (5 m m ) or GSH (10 m m ) plus diamide (1 m m ) for 
30 min at 37 ° C or by incubation with diamide alone (1 m m ) for 
10 min at 37 ° C. 5-LO was applied onto a 16/60 Superdex 200 pg 
column (GE Healthcare, Uppsala, Sweden) which was eluted with 
PBS containing 1 m m EDTA with or without addition of 0.5 % T20 
at a fl ow rate of 1 ml/min. UV absorbance was recorded at 211 nm. 
To calibrate the column, the standard proteins conalbumin (75 kDa), 
aldolase (158 kDa) and ferritin (440 kDa monomer, 880 kDa dimer) 
were used for each buffer. 
 Sample preparation and gel fi ltration of PMNL S100 
 A total of 2 × 10 9 cells were resuspended in PBS/EDTA containing 
60  µ g/ml soybean trypsin inhibitor, 0.4 m m PMSF and 10  µ g/ml 
leupeptin, homogenized by sonication (6 × 10 s) and centrifuged at 
100 000  g for 70 min at 4 ° C. Afterwards, the resulting supernatant 
was applied to the gel fi ltration column and eluted with PBS/EDTA 
at a fl ow rate of 1 ml/min. 
 Radioactive glutathione binding assay 
 5-LO (2.5  µ m ) was incubated with GSH (8.7 m m ), ( 35 S)-GSH 
(2.5  µ Ci) and diamide (0.87 m m ) for 30 min at 37 ° C and then ana-
lyzed via SDS-PAGE. ( 35 S)-GSH labeled proteins were detected using 
a Phosphorimager (Fuji FLA-3000, Fujifi lm, Düsseldorf, Germany). 
 Table 2  List and sequence of oligonucleotide primers used for construction of the 4C mutant. 
Primer Sequence (5 ′ → 3 ′ )
Forward Reverse
C159S CGATGCCAAAAGCCACAAGGATTTACCCCG CGGGGTAAATCCTTGTGGCTTTTGGCATCG
C300S CAAAACAGACCCCAGCACACTCCAGTTCCTG CAGGAACTGGAGTGTGCTGGGGTCTGTTTTG
C416/418S GCAGCTCATCAGCGAGAGTGGCCTCTTTGAC GTCAAAGAGGCCACTCTCGCTGATGAGCTGC
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 Determination of free cysteine residues using 
Ellman ’ s reagent and HPLC analysis 
 5-LO purifi ed by ion exchange chromatography was concentrated 
using Amicon Ultra-4 (10 kDa) columns (Millipore, Billerica, MA, 
USA), incubated with GSH and diamide as described above and 
subjected to the determination of thiols via HPLC quantifi cation as 
described previously (Chen et al. , 2008 ). 
 Determination of product formation of 5-LO 
 For determination of the activity of recombinant 5-LO and PMNL 
S100, 1 m m ATP was added to the resulting fractions of the gel fi ltra-
tion, the samples were prewarmed for 30 s at 37 ° C and 2 m m CaCl 2 
and 20  µ m AA were added to a fi nal incubation volume of 1 ml. The 
reaction was stopped after 10 min by the addition of 1 ml ice-cold 
methanol. The 5-LO products were extracted and analyzed by HPLC 
using PGB 1 as internal standard as described previously (Werz and 
Steinhilber , 1996 ). 
 SDS-PAGE and Western blot analysis 
 Samples derived from the gel fi ltration were mixed with 5 × SDS-
PAGE loading buffer (250 m m Tris/HCl, pH 6.8, 5 m m EDTA, 50 % 
glycerol, 10 % SDS, 0.05 % BPB, 10 % BME) and heated for 5 min 
at 95 ° C. The proteins were separated according to the protocol of 
Lae mmli (Laemmli , 1970 ). When disulfi de bonds were investigated 
the samples where boiled without addition of BME. The resulting 
gels were either stained with Coomassie blue or analyzed by Western 
blot (Michel et al. , 2008 ). The antibodies were diluted in TBS plus 
0.05 % FCS as follows: mouse 5-LO primary monoclonal antibody 
1:1000 (produced in-house, binds to the catalytic domain), anti-
mouse alkaline phosphatase-conjugated antibody 1:1000. 
 Laser induced liquid bead ion desorption (LILBID) 
measurement 
 The effect of diamide and glutathione were reassessed by a laser 
mass spectrometry (MS) method termed LILBID (laser induced 
liquid bead ion desorption). Details of the LILBID technique have 
been published elsewhere (Morgner et al. , 2006 ). Briefl y, aqueous 
micro droplets are transferred into vacuum where they are irradi-
ated one by one by pulsed infrared laser radiation, with a wave-
length corresponding to the water absorption ( λ = 3  µ m) leading to 
stretching vibration of the water molecules and transfer of energy to 
the droplets. Beyond a certain laser intensity threshold, the droplets 
 ‘ explode ’ and preformed ions are ejected from the liquid into the gas 
phase where they are analyzed by time-of-fl ight mass spectrometry 
(TOF-MS). For LILBID analysis, the phosphate buffer of the 5-LO 
protein samples was exchanged for a 100 m m ammonium hydrogen-
carbonate buffer pH 7.4 by utilizing Zeba Micro Spin Desalting 
Columns to avoid a high background signal that is caused by sodium 
ions contained in the phosphate buffer. In LILBID samples contain-
ing T20, the detergent (0.1 % ) was added after the buffer exchange 
except in diamide/glutathione-treated 5-LO samples, T20 was added 
before buffer exchange to avoid binding of the 5-LO to the buffer 
exchange column. 
 In silico restoration of the structure of WT 5-LO 
 The crystal structure of engineered human 5-LO {Protein Data Bank 
[PDB, http://pdb.org, (Berman et al. , 2000 ) ID: 3o8y (Gilbert et al. , 
2011 ), chain B]} was subjected to  in silico mutagenesis to restore 
the WT enzyme. For enabling crystallization and structure deter-
mination, Gilbert et al. mutated or deleted several amino acids to 
obtain the so-called  ‘ Stable-5LOX ’ (Gilbert et al. , 2011 ) which con-
tains the following mutations: W13E, F14H, W75G, L76S, C240A, 
C561A, K 653 KK 655  → ENL, and  ∆ P40 to D44GS. To restore the WT 
enzyme, we performed  in silico mutagenesis of the modifi ed residues 
and construction of the missing segment using the software package 
MOE (version 2010.10; Chemical Computing Group, Montreal, QC, 
Canada), which uses rotamer libraries, loop prediction (Fechteler et 
al. , 1995 ), and energy minimization to construct the missing or modi-
fi ed residues. Energy minimization was performed using the all-atom 
force fi eld AMBER99 (Wang et al. , 2000 ) with root mean square 
(RMS) gradient of 1. 
 Prediction of protein-protein interaction sites 
 Putative protein-protein interaction sites of 5-LO were indepen-
dently calculated using ProMate 2.0 ( http://bioinfo.weizmann.ac.il/
promate/ ) (Neuvirth et al. , 2004 ), Cons-PPISP ( http://pipe.scs.fsu.
edu/ppisp.html ) (Zhou and Shan , 2001 ; Chen and Zhou , 2005 ), 
PPI-Pred ( http://bmbpcu36.leeds.ac.uk/ppi_pred/ ) (Bradford and 
Westhead , 2005 ), and SPPIDER ( http://sppider.cchmc.org/ ) (Porollo 
and Meller , 2007 ). ProMate predicts the location of protein-protein 
binding sites in unbound proteins by extracting a set of surface patch-
es for the query protein. Using the distributions of the properties that 
have been found to distinguish binding from non-binding surfaces, 
the predictor evaluates the probability of each patch to appear in the 
interface. Cons-PPISP is a consensus neural network method that 
was trained on known structures of protein-protein complexes. The 
input to the neural network includes position-specifi c sequence pro-
fi les and solvent accessibilities of each residue and its spatial neigh-
bors. PPI-Pred calculates properties of the protein surface that allow 
for a distinction of protein-interfaces from the rest of the surface: 
hydrophobicity, residue interface propensity, electrostatic potential, 
solvent accessible surface area, surface topography (shape) and se-
quence conservation. SPPIDER uses relative solvent accessibility 
fi ngerprints to discriminate between interacting and non-interacting 
sites. 
 Protein-protein docking 
 The protein docking and clustering technique ClusPro (Comeau 
et al. , 2004 ) was used to predict a model of the overall structure of 
the 5-LO dimer using the  ‘ dimer ’ mode with balanced coeffi cients. 
One thousand low energy models were calculated and provided to 
the clustering algorithm, which clustered the results according to 
root mean square distance (RMSD). Clusters were ranked accord-
ing to cluster size and the ten top ranking clusters were retained. 
We manually evaluated these docking conformations combining the 
outcome of the protein-protein interaction site predictions and the 
experimental results. 
 Evaluation of the predicted dimer interface 
 The predicted dimer interface of 5-LO was compared with the inter-
faces of known homodimers using the PROTORP server (Reynolds 
et al. , 2009 ), which calculates a set of 26 physicochemical param-
eters exhibited by each protein interface. The dataset consists of 534 
non-homologous homodimers. Values for the calculated parameters 
are given as mean ± SD. Hydrogen-bond, salt bridge and disulfi de 
bond values were normalized to 100  Å 2 interface area. The parameter 
 ‘ bridging water molecule ’ was omitted. 
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 Calculation of cysteine pK a values 
 pK 
a
 values of cysteine residues of the restored 5-LO WT structure 
were calculated using the PROPKA web interface 2.0 ( http://propka.
ki.ku.dk/ ) (Li et al. , 2005 ; Bas et al. , 2008 ). 
 5-LO protein quantifi cation 
 The 5-LO protein concentration was determined by SDS-PAGE as 
described above with bovine serum albumin (BSA) as standard. 
Quantifi cation analysis was performed using an Odyssey  ®  Imaging 
System (Licor Biosciences, NE, USA). 
 Native gel electrophoresis 
 Native gel electrophoresis was performed as described previously 
(Betts et al. , 1999 ). In brief, the sample was mixed with 3 × sample 
buffer (0.6 ml 50 × running buffer, 3 ml glycerol (87 % ), 0.05 % BPB, 
and 10 ml purifi ed water) and applied to a native gel that consisted 
of a stacking gel (7 × stacking gel buffer: 0.5  m Tris, pH 6.8) and a 
resolving gel (4 × resolving gel buffer: 1.5  m Tris, pH 8.8). All solu-
tions were equilibrated to 4 ° C and electrophoresis was performed 
in a cold room at 4 ° C in native running buffer (50 × running buffer: 
248 m m Tris, 1.918  m glycine). Electrophoresis was started at 10 mA 
(300 V max) and increased up to 15 mA when the loading dye 
bromphenol blue entered the resolving gel. To investigate calcium 
dependence either 1 m m calcium or 1 m m EDTA was added to all 
buffers. 
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